TGF-β Signaling in Pancreatic Islet β Cell Development and Function.

Area of Science:

• Endocrinology
• Developmental Biology
• Molecular Signaling

Background:

• Pancreatic beta cells (β-cells) are central to glucose homeostasis and insulin secretion.
• Type 1 diabetes involves autoimmune β-cell destruction, while type 2 diabetes (T2D) features insulin resistance and eventual β-cell failure.
• β-cell mass and function dynamically change during development and in response to metabolic stress.

Purpose of the Study:

• To review the role of transforming growth factor beta (TGF-β) superfamily ligands in pancreatic β-cell biology.
• To explore TGF-β's involvement in normal β-cell development, growth, and function.
• To summarize TGF-β's contribution to diabetes pathogenesis and its therapeutic potential.

Main Methods:

• Literature review of studies on TGF-β signaling in pancreatic β-cells.
• Analysis of findings related to TGF-β in embryonic development, β-cell proliferation, differentiation, and apoptosis.
• Synthesis of evidence on TGF-β's role in adult β-cell mass regulation and function in diabetes.

Main Results:

• TGF-β pathway ligands are critical regulators of endocrine pancreas development.
• TGF-β influences β-cell proliferation, differentiation, and apoptosis.
• Emerging evidence suggests TGF-β regulates adult β-cell mass and function, implicating it in diabetes.

Conclusions:

• TGF-β signaling pathways are integral to pancreatic β-cell development and function.
• Dysregulation of TGF-β signaling contributes to diabetes pathogenesis.
• Targeting the TGF-β pathway presents a promising therapeutic avenue for diabetes treatment.